Skip to main content
OpenTrials
Completed

NCT Number: NCT05070988

Oral Health Related Quality of Life of Patients With Rare Diseases: a Qualitative Approach

The main objective of the study is to assess the oral health-related quality of life of patients with rare diseases and followed in the rare disease centers of expertise at Necker Hospital in Paris by semi-structured interviews.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Necker-Enfants Malades

Paris, 75015, France

About this study

To date, few studies have used the qualitative method to analyze the oral health-related quality of life and the oral health care pathways of patients with rare diseases, all health sectors combined. The quantitative studies carried out using standardized questionnaires offer only a partial view of how patients feel, both children and adults.

The main objective of the study is to assess the oral health-related quality of life of patients with rare diseases and followed in the rare disease centers of expertise at Necker Hospital in Paris by means of a semi-structured interview.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Minor and adult patients with rare diseases aged of at least 6 years old and followed at the Necker Enfant Malades Hospital, Paris
  • Patients with the 3 most frequent rare diseases of each rare disease Necker reference center participating in the study (10 centers : Chronic And Malformative Disorders Of The Esophagus / Inflammatory diseases of the bile ducts and autoimmune hepatitis / Constitutional Bone Diseases / Inherited Metabolic Diseases / Biliary Atresia And Genetic Cholestases / Vascular Diseases Of The Liver / Developmental Anomalies and Malformative Syndromes of Ile-De-France / Rare Causes Intellectual Disabilities / Complex congenital heart defects / Childhood cerebrovascular pathologies)
  • Patients who consulted between 1.1.2017 and 1.1.2020 the relevant rare disease reference center at Necker hospital
  • Patients seen at least once in the medical genetics department of Necker Hospital
  • Information and non-opposition of adult patients / holders of parental authority of minor patients and minor patients to participate in the study

Exclusion criteria

Patients who do not speak French

Treatment and study plan

semi-structured interview

Other

Semi-structured interview with the investigating doctor of the study lasting 30 minutes to an hour

Primary outcomes

  1. Oral health-related quality of life assessment

    Time frame: Day 0

    Qualitative method from a semi-structured interview.

Secondary outcomes

  1. Description of oral health care pathways

    Time frame: Day 0

    Description from the semi-structured interviews.

  2. Inequalities in access to oral health care

    Time frame: Day 0

    Description of inequalities in access to oral health care. Description from the semi-structured interviews.

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Collaborators

  • URC-CIC Paris Descartes Necker Cochin

Registry information

Official study title

Oral Health Related Quality of Life of Patients With Rare Diseases Followed at Necker Hospital: a Qualitative Approach

Acronym: RaroDentAXE3

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Oct 7, 2021
Registry last updated
Sep 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.